You are here: Industry Insights > revenue

News List

AstraZeneca Announces First Quarter 2021 Results americanpharmaceuticalreview
May 06, 2021
AstraZeneca delivered robust revenue growth of 15% (11% at CER) in the quarter to $7,320m; excluding the contribution from the pandemic COVID-19 vaccine, revenue growth increased by 11% (7% at CER) to $7,045m.
GSK reports decline in Q1 2021 revenue due to Covid-19 disruption pharmaceutical-technology
April 30, 2021
GlaxoSmithKline (GSK) has reported an 18% year-on-year (YOY) decline in revenue in the first quarter of this year to ￡7.41bn and down 15% at constant currency due to disruption caused by the global Covid-19 pandemic.
Eli Lilly reports increase in first-quarter worldwide revenue pharmaceutical-technology
April 29, 2021
Eli Lilly and Company has reported worldwide revenue of $6.806bn for the first quarter of this year, a 16% rise compared with the same quarter of last year.
PureTech Health reports increase in 2020 revenue pharmaceutical-technology
April 16, 2021
PureTech Health has reported an increase in revenue to $11.77m last year from $9.81m in 2019.
111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results prnasia
March 19, 2021
111, Inc. announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.
EDAN Announces 2020 Annual Results and 2025 Outlook: Revenues Increased 104.1% prnasia
March 17, 2021
EDAN Instruments, Inc. on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its anticipation for 2025.
Financial Report. Roche contractpharma
February 07, 2021
Newly launched medicines Tecentriq, Hemlibra, Ocrevus, Perjeta and Kadcyla offset the impact of competition from biosimilars for established medicines.
Regeneron 4Q and FY20 Results contractpharma
February 07, 2021
REGEN-COV antibody cocktail for COVID-19 received FDA EUA; Net sales of REGEN-COV were $146 million in the quarter and $186 million for the year.
Financial Report. Lilly contractpharma
February 07, 2021
Recognizes worldwide revenue of $871.2 million in the quarter for bamlanivimab COVID-19 treatment.
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results prnasia
November 18, 2020
China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.